Cho JY - Search Results

1

Nanomedicine for glioblastoma: Progress and future prospects.

Khan I, Baig MH, Mahfooz S, Imran MA, Khan MI, Dong JJ, Cho JY, Hatiboglu MA. Khan I, et al. Among authors: cho jy. Semin Cancer Biol. 2022 Nov;86(Pt 2):172-186. doi: 10.1016/j.semcancer.2022.06.007. Epub 2022 Jun 26. Semin Cancer Biol. 2022. PMID: 35760272 Review.

2

Impact of the Double Mutants on Spike Protein of SARS-CoV-2 B.1.617 Lineage on the Human ACE2 Receptor Binding: A Structural Insight.

Khan MI, Baig MH, Mondal T, Alorabi M, Sharma T, Dong JJ, Cho JY. Khan MI, et al. Among authors: cho jy. Viruses. 2021 Nov 17;13(11):2295. doi: 10.3390/v13112295. Viruses. 2021. PMID: 34835101 Free PMC article.

3

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

Cho JY, Paik YH, Chang YS, Lee SJ, Lee DK, Song SY, Chung JB, Park MS, Yu JS, Yoon DS. Cho JY, et al. Cancer. 2005 Dec 15;104(12):2753-8. doi: 10.1002/cncr.21591. Cancer. 2005. PMID: 16294346 Free article. Clinical Trial.

4

9-cis retinoic acid induces insulin-like growth factor binding protein-3 through DR-8 retinoic acid responsive elements.

Chang YS, Cho JY, Cho HA, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK. Chang YS, et al. Among authors: cho ha, cho jy. Cancer Biol Ther. 2006 Jun;5(6):586-92. doi: 10.4161/cbt.5.6.2658. Epub 2006 Jun 5. Cancer Biol Ther. 2006. PMID: 16760641

5

Prognostic factors of second and third line chemotherapy using 5-fu with platinum, irinotecan, and taxane for advanced gastric cancer.

Park JS, Lim JY, Park SK, Kim MK, Ko HS, Yoon SO, Kim JW, Choi SH, Cho JY. Park JS, et al. Among authors: cho jy. Cancer Res Treat. 2011 Dec;43(4):236-43. doi: 10.4143/crt.2011.43.4.236. Epub 2011 Dec 27. Cancer Res Treat. 2011. PMID: 22247709 Free PMC article.

6

Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).

Kim Y, Lee SJ, Lee JY, Lee SH, Sun JM, Park K, An HJ, Cho JY, Kang EJ, Lee HY, Kim J, Keam B, Kim HR, Lee KE, Choi MY, Lee KH, Ahn MJ. Kim Y, et al. Among authors: cho jy. Cancer. 2017 Jun 1;123(11):1958-1964. doi: 10.1002/cncr.30537. Epub 2017 Jan 19. Cancer. 2017. PMID: 28102887 Free article. Clinical Trial.

7

Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer.

Kim B, Kim Y, Shin S, Lee ST, Cho JY, Lee KA. Kim B, et al. Among authors: cho jy. Cancer Cell Int. 2022 Feb 15;22(1):82. doi: 10.1186/s12935-022-02504-2. Cancer Cell Int. 2022. PMID: 35168603 Free PMC article.

8

Treatment outcome of patients with anaplastic thyroid cancer: a single center experience.

Lim SM, Shin SJ, Chung WY, Park CS, Nam KH, Kang SW, Keum KC, Kim JH, Cho JY, Hong YK, Cho BC. Lim SM, et al. Among authors: cho jy, cho bc. Yonsei Med J. 2012 Mar;53(2):352-7. doi: 10.3349/ymj.2012.53.2.352. Yonsei Med J. 2012. PMID: 22318823 Free PMC article.

9

Molecular diagnosis for personalized target therapy in gastric cancer.

Cho JY. Cho JY. J Gastric Cancer. 2013 Sep;13(3):129-35. doi: 10.5230/jgc.2013.13.3.129. Epub 2013 Sep 30. J Gastric Cancer. 2013. PMID: 24156032 Free PMC article. Review.

10

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer.

Lim JY, Cho JH, Lee SJ, Lee DK, Yoon DS, Cho JY. Lim JY, et al. Among authors: cho jh, cho jy. Cancer Res Treat. 2015 Apr;47(2):266-73. doi: 10.4143/crt.2013.158. Epub 2014 Aug 29. Cancer Res Treat. 2015. PMID: 25327494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,578 results

Search Page